Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus paclitaxel for recurrent or metastatic head and neck cancer
NCT01333852Phase 2Terminated
- Start
- Feb 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in head and neck squamous cell carcinoma (HNSCC). Started Feb 2011; status: terminated.
02
Drugs
metformin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01333852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333852.